SCHEDULE 13G/A 0000902664-25-003539 0001230239 XXXXXXXX LIVE 1 Class A Common Stock, par value $0.00001 per share 12/31/2025 0001673743 Hinge Health, Inc. 433313103 455 MARKET STREET 7TH FLOOR SAN FRANCISCO CA 94105 Rule 13d-1(d) Alkeon Capital Management LLC DE 0.00 791104.00 0.00 791104.00 791104.00 N 2.1 IA OO Panayotis D. Sparaggis X1 0.00 791104.00 0.00 791104.00 791104.00 N 2.1 HC IN Hinge Health, Inc. 455 Market Street, Suite 700, San Francisco, CA 94105 This statement is filed by: (i) Alkeon Capital Management LLC ("Alkeon"), a Delaware limited liability company and the investment manager to certain funds (the "Alkeon Funds"), with respect to the shares of Class A Common Stock, par value $0.00001 per share ("Class A Common Stock") of Hinge Health, Inc., a Delaware corporation (the "Company") directly held by the Alkeon Funds; and (ii) Panayotis D. Sparaggis ("Mr. Sparaggis"), the Founder and Managing Director of Alkeon, with respect to the shares of Class A Common Stock directly held by the Alkeon Funds. The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons." The filing of this statement should not be construed as an admission that any of the foregoing persons or any Reporting Person is, for the purposes of Section 13 of the Securities Exchange Act of 1934, the beneficial owner of the securities reported herein. The address of the business office of each of the Reporting Persons is 350 Madison Avenue, 20th Floor, New York, NY 10017. The Investment Manager is a Delaware limited liability company. Mr. Sparaggis is a citizen of the United States. Y The information required by Item 4(a) is set forth in Row 9 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The percentage set forth in this Schedule 13G is calculated based upon an aggregate of 37,919,155 shares of Class A Common Stock outstanding as of October 30, 2025, as reported in the Company's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025, filed with the Securities and Exchange Commission on November 7, 2025. 2.1% The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference. N Y N See Item 2(a). Y Y Y Y Alkeon Capital Management LLC /s/ Jennifer Shufro 02/13/2026 Panayotis D. Sparaggis /s/ Panayotis D. Sparaggis 02/13/2026